Neil Belloff
General Counsel bei ACORDA THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Neil Belloff
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACORDA THERAPEUTICS, INC. | General Counsel | 08.11.2021 | - |
| Unternehmenssekretär | 01.06.2022 | - |
Karriereverlauf von Neil Belloff
Ehemalige bekannte Positionen von Neil Belloff
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ELOXX PHARMACEUTICALS, INC. | Geschäftsführer | 01.02.2020 | 25.08.2021 |
| General Counsel | 18.06.2018 | 25.08.2021 | |
| Unternehmenssekretär | 18.06.2018 | 25.08.2021 | |
| CELGENE | Corporate Officer/Principal | 01.01.2011 | - |
| DEUTSCHE TELEKOM AG | Corporate Officer/Principal | - | - |
Ausbildung von Neil Belloff
| Quinnipiac University School of Law | Graduate Degree |
| New York University | Graduate Degree |
| Queens College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Deutschland | 2 |
Operativ
| General Counsel | 2 |
| Corporate Secretary | 2 |
| Graduate Degree | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
| Communications | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| DEUTSCHE TELEKOM AG | Communications |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Börse
- Insiders
- Neil Belloff
- Erfahrung
